by VS3 Medical | Sep 29, 2026 | Press Release
SAN JOSE, Calif., September 29, 2026 — VS3 Medical, Inc., a private company developing novel neurovascular implants, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its VS3 System. The designation...
by VS3 Medical | Mar 9, 2026 | Press Release
San Jose, Calif., March 9, 2026 — VS3 Medical, Inc., a private company developing novel neurovascular implants, today announced it has commenced enrollment in its international first-in-human (FIH) study evaluating its VS3 Medical™ Stent System for patients with...
